![Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]](https://i.ytimg.com/vi/ffcHWDpKZqQ/maxresdefault.jpg)
Dr. Ai on Potential With Mogamulizumab in CTCL
3 vistas
• 08/09/23
0
0
Empotrar
administrator
Suscriptores
Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios